New Leadership Appointments Signal Major Shift in NZ’s Health Research and Innovation Strategy

Announcing the appointments, Mr Brown said the refreshed Board would help guide the HRC through an increasingly important period for New Zealand’s healthcare system and research ecosystem.

New Zealand's health research sector is entering a new phase of leadership and reform, with Health Minister Simeon Brown announcing three significant appointments to the Board of the Health Research Council (HRC) — moves aimed at strengthening governance, accelerating innovation, and aligning the country's research priorities with future healthcare challenges.

Dr Margaret Whilsher, Dr Colin McArthur, and former MP Paul Foster-Bell have each been appointed to the HRC Board for three-year terms, joining a leadership team tasked with overseeing one of New Zealand's most influential scientific and medical funding institutions.

At the same time, Professor Lester Levy has been reappointed as Chair and Jeroen Douwes as Deputy Chair for a further three years, ensuring continuity during a period of major restructuring across New Zealand's science and innovation sector.

The Health Research Council is the Government's principal agency responsible for investing in health research, distributing millions of dollars annually into medical science, public health, biotechnology, clinical innovation, and emerging healthcare technologies. The organisation also advises ministers on national research priorities and plays a critical role in translating scientific discoveries into practical healthcare outcomes.

Announcing the appointments, Mr Brown said the refreshed Board would help guide the HRC through an increasingly important period for New Zealand's healthcare system and research ecosystem.

"The Health Research Council plays a central role in managing the Government's investment in health research," Mr Brown said.

"This includes advising the Health Minister on national health research policy, administering funds, encouraging and initiating health research, and disseminating the findings of health research."

The Minister said the appointments reflected the Government's intention to maintain strong governance and strategic stability as reforms reshape the wider science sector.

"These appointments and reappointments reflect the need to maintain a strong and balanced Board that can provide stability and effective governance as the organisation undergoes significant change as part of wider science sector reforms," he said.

The appointments come at a time when global health systems are under pressure to modernise rapidly in response to aging populations, workforce shortages, mental health demands, chronic disease burdens, and the growing role of artificial intelligence and digital medicine in healthcare delivery.

Experts say strong research governance will be crucial as New Zealand seeks to remain competitive internationally in areas such as biomedical innovation, precision medicine, Indigenous health research, pharmaceutical development, and public health resilience.

The HRC has historically funded groundbreaking work in cancer treatment, cardiovascular disease, mental health, infectious diseases, Māori health equity, and population health science. Its research investments have helped shape public health responses, informed clinical practice, and strengthened New Zealand's international scientific partnerships.

The Board's new composition brings together expertise spanning medicine, governance, public policy, health systems, and academia — a blend viewed as increasingly important as research organisations face pressure to deliver both scientific excellence and measurable societal outcomes.

Professor Lester Levy's reappointment as Chair is expected to provide continuity and institutional experience during ongoing sector reform discussions. Levy has held multiple senior leadership positions across New Zealand's health sector and is widely regarded for his expertise in governance, healthcare management, and organisational transformation.

Deputy Chair Jeroen Douwes also returns with extensive experience in public health and environmental health research, while continuing Board members — Professor Cameron Grant, Professor Brett Cowan, Professor James MacLaurin, Dr Frances Hughes, and Associate Professor Riz Firestone — provide continuity across clinical medicine, research strategy, health equity, and scientific leadership.

Observers note that the appointments signal the Government's intention to ensure the HRC remains both scientifically credible and strategically aligned with broader economic and healthcare priorities.

The announcement also highlights the increasing importance governments worldwide are placing on research commercialisation and innovation-led healthcare growth. Globally, health research investment has become a key driver of biotechnology industries, pharmaceutical breakthroughs, and digital health innovation, sectors collectively worth trillions of dollars annually.

For New Zealand, maintaining a strong and effective HRC is seen as critical not only for improving health outcomes but also for supporting economic growth through science and innovation.

The new Board appointments take effect immediately.